Abstract
The fast and slow skeletal muscle fibers in fish are separated to a much greater degree than in mammals. MyoD is required for the maintenance of normal fiber type balance in muscles. So far, the upstream regulatory factors of MyoD in terms of controlling muscle phenotype are poorly understood. In the present study, we used Siniperca chuatsi as a model system and demonstrated that miR-143 expression was negatively correlated with MyoD expression in the fast and slow muscles of S. chuatsi. The luciferase reporter assay further verified the direct interaction between the miR-143 and MyoD. The miR-143 suppression also led to the significant increase in MyoD and fast myosin heavy chain gene expression in vivo. Taken together, our studies indicated that miRNA participates in controlling the performance of different muscle fiber types in vertebrates.
Keywords: microRNA, muscle fiber, MyoD, regulation, Siniperca chuatsi.
Current Molecular Medicine
Title:miR-143: A Novel Regulator of MyoD Expression in Fast and Slow Muscles of Siniperca chuatsi
Volume: 14 Issue: 3
Author(s): L. Chen, P. Wu, X.-H. Guo, Y. Hu, Y.-L. Li, J. Shi, K.-Z. Wang, W.-Y. Chu and J.-S. Zhang
Affiliation:
Keywords: microRNA, muscle fiber, MyoD, regulation, Siniperca chuatsi.
Abstract: The fast and slow skeletal muscle fibers in fish are separated to a much greater degree than in mammals. MyoD is required for the maintenance of normal fiber type balance in muscles. So far, the upstream regulatory factors of MyoD in terms of controlling muscle phenotype are poorly understood. In the present study, we used Siniperca chuatsi as a model system and demonstrated that miR-143 expression was negatively correlated with MyoD expression in the fast and slow muscles of S. chuatsi. The luciferase reporter assay further verified the direct interaction between the miR-143 and MyoD. The miR-143 suppression also led to the significant increase in MyoD and fast myosin heavy chain gene expression in vivo. Taken together, our studies indicated that miRNA participates in controlling the performance of different muscle fiber types in vertebrates.
Export Options
About this article
Cite this article as:
Chen L., Wu P., Guo X.-H., Hu Y., Li Y.-L., Shi J., Wang K.-Z., Chu W.-Y. and Zhang J.-S., miR-143: A Novel Regulator of MyoD Expression in Fast and Slow Muscles of Siniperca chuatsi, Current Molecular Medicine 2014; 14 (3) . https://dx.doi.org/10.2174/1566524014666140228100250
DOI https://dx.doi.org/10.2174/1566524014666140228100250 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of Benzodiazepine and Pilocarpine on Rat Parotid Glands: Histomorphometric And Sialometric Study
Medicinal Chemistry Medical Nanorobot Architecture Based on Nanobioelectronics
Recent Patents on Nanotechnology Imaging Epigenetics in Alzheimer’s Disease
Current Pharmaceutical Design Exosomes: Natural Carriers for siRNA Delivery
Current Pharmaceutical Design Immunogenicity and Tumorigenicity of Pluripotent Stem Cells and their Derivatives: Genetic and Epigenetic Perspectives
Current Stem Cell Research & Therapy Carbonic Anhydrase Related Protein VIII and its Role in Neurodegeneration and Cancer
Current Pharmaceutical Design Somatic Genomic Variations in Extra-Embryonic Tissues
Current Genomics Oxidative stress and myocarditis
Current Pharmaceutical Design Potential of Modulating Wnt Signaling Pathway Toward the Development of Bone Anabolic Agent
Current Molecular Pharmacology Rational Targeting of the Urokinase Receptor (uPAR): Development of Antagonists and Non-Invasive Imaging Probes
Current Drug Targets State of the Art of the Bi- and Trimetallic Nanoparticles on the Basis of Gold and Iron
Recent Patents on Nanotechnology Specific Biologic Therapy with Tumor Necrosis Factor Inhibitors in Patients with Inflammatory Myopathy
Current Rheumatology Reviews Biosynthesis and Biological Activities of In Vitro Derived Solasodine Glycoalkaloids from <i>Solanum laciniatum</i>
The Natural Products Journal Editorial
Current Angiogenesis (Discontinued) Probiotics for the Prevention and Treatment of Allergies, with an Emphasis on Mode of Delivery and Mechanism of Action
Current Pharmaceutical Design Efficacy and Cardiovascular Safety of Metformin
Current Drug Safety Mechanisms Underlying Chemopreventive Effects of Flavonoids via Multiple Signaling Nodes within Nrf2-ARE and AhR-XRE Gene Regulatory Networks
Current Chemical Biology Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry Skin Cancers in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Atorvastatin-Loaded Oleic Acid Nanoglobules for Oral Administration: In Vitro Characterization and Biopharmaceutical Evaluation
Current Nanoscience